Examining the development of pharmacist-physician collaboration over 3 months

被引:34
|
作者
Liu, Yifei [1 ]
Doucette, William R. [2 ]
Farris, Karen B. [2 ]
机构
[1] Univ Missouri, Sch Pharm, Div Pharm Practice & Adm, Kansas City, MO 64108 USA
[2] Univ Iowa, Coll Pharm, Div Hlth Serv Res, Iowa City, IA 52242 USA
来源
关键词
Pharmacist-physician collaboration; The model of collaborative working relationship (CWR); Collaborative care; MEDICATION THERAPY MANAGEMENT; CLINICAL PHARMACIST; DISEASE MANAGEMENT; EVENTS; IMPACT; TRIAL; COST;
D O I
10.1016/j.sapharm.2009.11.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Pharmacist-physician collaboration may result in improved patient care. The model of collaborative working relationship (CWR) synthesizes such collaboration into 5 progressive stages, which are impacted by individual, context, and exchange characteristics; however, no study has demonstrated how to distinguish the 5 collaborative stages. Objective: Using CWR, the study objective was to identify factors associated with pharmacist-physician collaboration at baseline and at 3 months. Methods: This study consisted of 2 self-administered surveys mailed to a random sample of 750 Iowa pharmacists. The first survey assessed collaborative care at baseline and individual, context; and exchange characteristics. The second survey assessed collaborative care 3 months later. The measures for CWR constructs were modified from previously validated instruments. Individual characteristics; context characteristics, including practice setting, professional interaction, current collaboration status (yes/no); and exchange characteristics, including relationship initiation, trustworthiness, and role specification were obtained. Descriptive statistics, reliability analysis, and bivariate correlations were performed. Two regressions were conducted, wherein collaborative care at baseline and at 3 months were regressed over relationship initiation, trustworthiness, role specification, professional interaction, current collaboration, practice setting, and physician specialty, wherein the data for independent variables collected at baseline were used in both regression procedures. Results: Response rates were 33% (n = 239) and 79% (n = 188) for the first and second surveys, respectively. In the regression analyses, 85% and 35% of the variance in collaborative care at baseline and at 3 months, respectively, were explained. Trustworthiness and role specification were 2 predictors of collaborative care at baseline, and trustworthiness and professional interaction were 2 predictors of collaborative care at 3 months. Conclusions: Different factors were associated with collaborative care at different study times, which support a dynamic model of CWR. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:324 / 333
页数:10
相关论文
共 50 条
  • [1] The physician perspective on pharmacist-physician collaboration and trust
    Amin, Sana
    McKeirnan, Kimberly C.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (04) : 1304 - 1312
  • [2] The Pharmacist-Physician Collaboration for IPW: From Physician's Perspective
    Son, Daisuke
    Kawamura, Kazumi
    Nakashima, Mitsuko
    Utsumi, Miho
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (01): : 109 - 115
  • [3] Impact of Pharmacist-Physician Collaboration on Osteoporosis Treatment Rates
    Bowers, Brandi L.
    Drew, Amy M.
    Verry, Christian
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (09) : 876 - 883
  • [4] Pharmacist-physician collaboration to manage hypertension in community pharmacy
    Vassallo, F.
    Wirth, F.
    Azzopardi, L. M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1505 - 1506
  • [5] Pharmacist-physician collaboration improves blood pressure control
    Albsoul-Younes, Abla M.
    Hammad, Eman A.
    Yasein, Nada A.
    Tahaineh, Linda M.
    [J]. SAUDI MEDICAL JOURNAL, 2011, 32 (03) : 288 - 292
  • [6] Pharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes
    Howard-Thompson, Amanda
    Farland, Michelle Z.
    Byrd, Debbie C.
    Airee, Anita
    Thomas, Jeremy
    Campbell, Jennifer
    Cassidy, Regina
    Morgan, Timothy
    Suda, Katie J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1471 - 1477
  • [7] Pharmacist-physician collaboration for diabetes care: the diabetes initiative program
    Farland, Michelle Z.
    Thomas, Jeremy L.
    Byrd, Debbie C.
    McFarland, M. Shawn
    Franks, Andrea S.
    George, Christa M.
    Guirguis, Alexander B.
    Gross, Benjamin N.
    Suda, Katie J.
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E251 - E252
  • [8] Validation of pharmacist-physician collaboration in psychiatry: "the Eichberger-model'
    Hahn, Martina
    Ritter, Christoph
    Roll, Sibylle C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (05) : 1001 - 1004
  • [9] Pharmacist-physician collaboration in perioperative medication reconciliation: the IMPROVE clinic
    Cogan, Patrick
    Pierini, Danielle
    Anderson, Katherine Vogel
    Rosenberg, Eric
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E267 - E267
  • [10] Louisiana State Policies Prove Problematic for Pharmacist-Physician Collaboration
    Hamilton, Anna L.
    Darr, Marie
    [J]. PREVENTING CHRONIC DISEASE, 2020, 17